Skip to content

Establishment Labs ESTA Remainder of 2026

Remainder of 2026 at other companies

Globus Medical logo
Globus MedicalGMED
Solventum logo
SolventumSOLV
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's remainder of 2026.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's remainder of 2026?
Establishment Labs (ESTA) reported remainder of 2026 of $2.07M in Q1 2026.
How has Establishment Labs's remainder of 2026 changed year-over-year?
Establishment Labs's remainder of 2026 decreased by 11.4% year-over-year, from $2.33M to $2.07M.